Connor, Clark & Lunn Investment Management (CC&L)’s Dynavax Technologies DVAX Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio DVAX Stock Details DVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-72,428	Closed	-$1.11M	–	1601
2025 Q4	$1.11M	Sell	72,428 -440,985	-86%	-$4.86M	﹤0.01%	1102
2025 Q3	$5.1M	Buy	513,413 +260,909	+103%	+$2.72M	0.02%	573
2025 Q2	$2.5M	Sell	252,504 -84,447	-25%	-$890K	0.01%	795
2025 Q1	$4.37M	Buy	+336,951	New	+$4.46M	0.02%	532
2017 Q1	–	Sell	-14,854	Closed	-$59K	–	935
2016 Q4	$59K	Buy	+14,854	New	+$109K	﹤0.01%	854

Other funds holding DVAX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s DVAX Position: Q1 2026 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 72,428 shares — an estimated $1.11M sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in DVAX in Q4 2016 and held it in 5 quarters. The position peaked at $5.1M in Q3 2025. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.

Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
Connor, Clark & Lunn Investment Management (CC&L) sold 72,428 Dynavax Technologies shares in Q1 2026, an estimated $1.11M.
Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Dynavax Technologies in Q4 2016 and held it in 5 quarters.
Connor, Clark & Lunn Investment Management (CC&L)'s Dynavax Technologies position peaked at $5.1M in Q3 2025.
1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q1 2026, filed 11 May 2026.